We are live on ! Find out more
RXL icon

ProShares Ultra Health Care

16 hedge funds and large institutions have $6.64M invested in ProShares Ultra Health Care in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $6.16M → $6.64M (+$481K)

0% more funds holding

Funds holding: 1616 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.38% less ownership

Funds ownership: 29.26%28.88% (-0.38%)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
16
Holders Change
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
6
Closed
3
Calls
$1.18M
Puts
Net Calls
+$1.18M
Net Calls Change
+$1.18M

RXL Hedge Fund Activity: Q2 2017 in Review

16 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q2 2017, worth a combined $6.64M — up 7.8% from $6.16M a quarter earlier.

Fund positioning in RXL was balanced in Q2 2017: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 6 trimmed.

The largest buyer was Geneos Wealth Management, opening a new position worth an estimated $1.15M. The largest seller was Susquehanna International Group, cutting an estimated $1.07M.

  • 16 institutional investors held ProShares Ultra Health Care (RXL) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $6.64M of ProShares Ultra Health Care stock for Q2 2017, up 7.8% quarter-over-quarter.
  • 3 funds opened new ProShares Ultra Health Care positions in Q2 2017 and 3 closed out, a net change of 0 holders.
  • The largest ProShares Ultra Health Care buyer in Q2 2017 was Geneos Wealth Management, an estimated $1.15M added.
  • The largest ProShares Ultra Health Care seller in Q2 2017 was Susquehanna International Group, an estimated $1.07M sold.

Based on aggregated 13F filings for Q2 2017.